4
Changes in Ownership
ClearPoint Neuro, Inc. Filed Acc 0001193125-26-234575
Director sold 5,091 shares at $11.14 ($56,714)
- Director acquired 12,417 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
FALLON LYNNETTE C · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-05-19 | Exercise or conversion : show line 1 in the form 10b5-1 | +12,417 | 53,318 | D | ||
| 2026-05-20 | Sale : show line 2 in the form 10b5-1 | −5,091 | $11.14 | $56,714 | 48,227 | D |
| Open-market sales · 5,091 sh · avg $11.14 · $56,714 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-05-19 | Exercise or conversion : show line 3 in the form 10b5-1 Restricted Stock Units | −12,417 | 0 | D |
Loading xslF345X06/ownership.xml…